Nurix Therapeutics's market cap is currently $1.29B. The company's EPS TTM is $-2.889; its P/E ratio is ―; Nurix Therapeutics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 54.55M	$ 76.99M	$ 38.63M	$ 29.75M	$ 17.82M
Gross Profit	$ 54.55M	$ -112.16M	$ 27.82M	$ 23.67M	$ -48.67M
Operating Income	$ -213.03M	$ -155.06M	$ -183.87M	$ -117.89M	$ -64.98M
EBITDA	$ -213.03M	$ -141.41M	$ -173.06M	$ -111.80M	$ -62.80M
Net Income	$ -193.57M	$ -143.95M	$ -166.04M	$ -117.19M	$ -43.24M
Balance Sheet
Cash & Short-Term Investments	$ 609.58M	$ 287.91M	$ 309.14M	$ 295.72M	$ 281.15M
Total Assets	$ 669.34M	$ 355.60M	$ 416.76M	$ 476.77M	$ 396.34M
Total Debt	$ 28.30M	$ 30.61M	$ 11.96M	$ 13.04M	$ 0.00
Net Debt	$ -81.69M	$ -24.01M	$ -52.51M	$ -67.47M	$ -119.36M
Total Liabilities	$ 142.35M	$ 155.10M	$ 113.06M	$ 134.47M	$ 106.07M
Stockholders' Equity	$ 526.99M	$ 200.49M	$ 303.70M	$ 342.30M	$ 290.27M
Cash Flow
Free Cash Flow	$ -181.86M	$ -89.77M	$ -172.05M	$ -90.03M	$ -4.63M
Operating Cash Flow	$ -172.58M	$ -81.36M	$ -159.81M	$ -84.36M	$ -80.00K
Investing Cash Flow	$ -257.71M	$ 68.30M	$ 27.20M	$ -108.25M	$ -254.40M
Financing Cash Flow	$ 485.67M	$ 3.22M	$ 117.19M	$ 153.88M	$ 339.02M

Currency in USD

Nurix Therapeutics Earnings and Revenue History

Income Statement >

Nurix Therapeutics Debt to Assets

Balance Sheet >

Nurix Therapeutics Cash Flow

Cash Flow >

Nurix Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing